Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter phase II study with pemetrexed in patients with pre-treated metastatic soft tissue sarcomas
2006-003816-23Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed in soft tissue sarcoma (STS), sponsored by University Hospital Tübingen. Primary endpoint: Rate of response. Started Oct 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2006-003816-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003816-23.